These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37406742)
1. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway. Xia P; Liu DH; Wang D; Wen GM; Zhao ZY Free Radic Biol Med; 2023 Sep; 206():125-133. PubMed ID: 37406742 [TBL] [Abstract][Full Text] [Related]
2. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles. Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903 [TBL] [Abstract][Full Text] [Related]
3. Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking. Guillot A; Ren T; Jourdan T; Pawlosky RJ; Han E; Kim SJ; Zhang L; Koob GF; Gao B Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25974-25981. PubMed ID: 31792171 [TBL] [Abstract][Full Text] [Related]
4. ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis. Jin S; Chen J; Chen L; Histen G; Lin Z; Gross S; Hixon J; Chen Y; Kung C; Chen Y; Fu Y; Lu Y; Lin H; Cai X; Yang H; Cairns RA; Dorsch M; Su SM; Biller S; Mak TW; Cang Y Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9088-93. PubMed ID: 26150517 [TBL] [Abstract][Full Text] [Related]
5. Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency. Montel RA; Munoz-Zuluaga C; Stiles KM; Crystal RG Cancer Gene Ther; 2022 Jul; 29(7):889-896. PubMed ID: 34799722 [TBL] [Abstract][Full Text] [Related]
6. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development. Yang D; Hu Y; Yang J; Tao L; Su Y; Wu Y; Yao Y; Wang S; Ye S; Xu T J Pharmacol Exp Ther; 2024 Apr; 389(2):163-173. PubMed ID: 38453527 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice. Hirohashi K; Ohashi S; Amanuma Y; Nakai Y; Ida T; Baba K; Mitani Y; Mizumoto A; Yamamoto Y; Kikuchi O; Matsubara J; Yamada A; Miyamoto S; Seno H; Matsuda T; Muto M Carcinogenesis; 2020 Apr; 41(2):194-202. PubMed ID: 31074772 [TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Kwon HJ; Won YS; Park O; Chang B; Duryee MJ; Thiele GE; Matsumoto A; Singh S; Abdelmegeed MA; Song BJ; Kawamoto T; Vasiliou V; Thiele GM; Gao B Hepatology; 2014 Jul; 60(1):146-57. PubMed ID: 24492981 [TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis. Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454 [TBL] [Abstract][Full Text] [Related]
13. The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases. Wu YC; Yao Y; Tao LS; Wang SX; Hu Y; Li LY; Hu S; Meng X; Yang DS; Li H; Xu T Cell Signal; 2023 Feb; 102():110550. PubMed ID: 36464104 [TBL] [Abstract][Full Text] [Related]
14. AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells. Sanchez AC; Li C; Andrews B; Asenjo JA; Samulski RJ Hum Gene Ther; 2017 Sep; 28(9):717-725. PubMed ID: 28578603 [TBL] [Abstract][Full Text] [Related]
15. ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Flashner S; Shimonosono M; Tomita Y; Matsuura N; Ohashi S; Muto M; Klein-Szanto AJ; Alan Diehl J; Chen CH; Mochly-Rosen D; Weinberg KI; Nakagawa H Carcinogenesis; 2024 Feb; 45(1-2):95-106. PubMed ID: 37978873 [TBL] [Abstract][Full Text] [Related]
16. Use of an "acetaldehyde clamp" in the determination of low-KM aldehyde dehydrogenase activity in H4-II-E-C3 rat hepatoma cells. Moncada C; Fuentes N; Lladser A; Encina G; Sapag A; Karahanian E; Israel Y Alcohol; 2003; 31(1-2):19-24. PubMed ID: 14615007 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo. Chen CH; Cruz LA; Mochly-Rosen D Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3074-9. PubMed ID: 25713355 [TBL] [Abstract][Full Text] [Related]
18. Effects of Gene Polymorphisms, Metabolic Activity, and Content of Alcohol Dehydrogenase and Acetaldehyde Dehydrogenases on Prognosis of Hepatocellular Carcinoma Patients. Gao N; Chen J; Qi B; Zhao T; Guo Y; Fang Y; Han Z; Qiao HL Turk J Gastroenterol; 2022 Jul; 33(7):606-614. PubMed ID: 35879918 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and the blood and salivary ethanol and acetaldehyde concentrations of Japanese alcoholic men. Yokoyama A; Tsutsumi E; Imazeki H; Suwa Y; Nakamura C; Yokoyama T Alcohol Clin Exp Res; 2010 Jul; 34(7):1246-56. PubMed ID: 20477767 [TBL] [Abstract][Full Text] [Related]
20. Transformed ALDH2 Zhang XN; Meng FG; Wang YR; Liu SX; Zeng T Med Hypotheses; 2021 Jan; 146():110366. PubMed ID: 33208242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]